About us
Who we are
Who we are
GAMA Healthcare is a dynamic, innovative company at the forefront of infection prevention technology. We specialise in the manufacture of revolutionary IPC products.
What we do
What we do
We help keep people safe. Our cutting-edge research lets us offer a wide range of effective, pioneering IPC solutions as well as unparalleled training and support.
Responsibility
Responsibility
We're proud to act responsibly as an employer, as a manufacturer and as a part of the global IPC community, holding ourselves to high standards across all our operations.
Sustainability
Sustainability
Our mission is to keep people safe from infection, whilst protecting our environment. Read about our efforts in sustainability and how we're making a difference.
Charity
Charity
We're stronger when we work together and preventing infections takes collaboration. Find out how we build partnerships with charities that share our purpose.
Careers
Careers
As an ever-growing company, we provide a wide variety of career opportunities and always take an active role in developing our people, to see them thrive in their roles.
About us
At GAMA we help prevent infections to save and improve lives. Find out what makes us one of the fastest-growing healthcare companies, leading the way in IPC.
Products
Our products
Our products
Our aim is to produce effective and clinically proven infection prevention products. Available across the globe, they help reduce the spread of infections and save lives.
By brand
Clinell
Clinell
Combining innovative technology with ease of use, Clinell products provide the most effective IPC solution.
Rediroom
Rediroom
Instant temporary isolation room to provide hospitals with flexibility and improve their isolation capacity.
Rediair
Rediair
Instant air filtration. A mobile solution to help stop the spread of infection in poorly ventilated spaces.
HEXI PREP
HEXI PREP
A pharmaceutical pad utilising 2% Chlorhexidine Digluconate in 70% Isopropyl Alcohol, designed for skin disinfection before vascular access procedures.
Carell
Carell
Our gentle, dermatologically-tested products help healthcare professionals with every aspect of patient care.
Contiplan
Contiplan
Full continence care regimen in a single wipe. Contiplan cleanses, moisturises and protects in one easy step.
Cleanall
Cleanall
Designed for general cleaning tasks, Cleanall range of cleaning cloths are strong, durable and very absorbent.
By sector
For hospitals
For hospitals
Our products are used in 9 out of 10 NHS hospitals. Designed by doctors to protect staff and patients.
For home
For home
NHS' number 1 disinfectant wipes, now available for personal use, to help protect your home and loved ones.
For workplaces
For workplaces
Making workplaces safer, GAMA offers a professional range of products to secure your staff and business.
For schools
For schools
Improving surface hygiene is one of the most effective ways to stop the spread of infection in schools.
For dental teams
For dental teams
Clinically proven products, compatible with dental and medical equipment to protect your patients and staff.
For pharmacies
For pharmacies
Clinically proven products providing pharmacists with the most effective cleaning and disinfection solutions.
For vets
For vets
Clinically proven products providing veterinary practices with the most effective cleaning and disinfection solutions.
By category
Surface care
Surface care
Professional IPC solutions ideal for use on both surfaces and non-invasive medical devices.
Hand hygiene
Hand hygiene
Clinically proven and dermatologically tested products to keep hands healthy and safe.
Skin care
Skin care
Reduce infection and promote personal hygiene with our comprehensive range of skin care products.
Patient isolation
Patient isolation
Instant isolation solutions to protect members of staff and patients under contact and droplet precautions.
Support products
Support products
Our support range provides solutions to promote best practice and increase compliance, keeping patients safe.
Compatibility
Compatibility
Check which of our products are compatible with your equipment and find out why compatibility matters, how it works and what you can do to safeguard your surfaces.
Products
Our aim is to produce effective and clinically proven infection prevention products. Available across the globe, they help reduce the spread of infections and save lives.
Training
Training
Training
GAMA’s engaging, interactive training programme was developed in collaboration with leading infection prevention specialists, to fit your organisation's needs.
Training
GAMA’s engaging, interactive training programme was developed in collaboration with leading infection prevention specialists, to fit your organisation's needs.
Research
Research
Research
At our cutting-edge facility, Fellows Research Centre in Halifax, our R&D team is committed to creating novel infection prevention solutions and protecting patients.
Research
At our cutting-edge facility, Fellows Research Centre in Halifax, our R&D team is committed to creating novel infection prevention solutions and protecting patients.
Latest news
GAMA Blog
GAMA Blog
Find out about the latest developments in the GAMA world, summaries of the recent research papers and read about our team, our events and the latest product launches.
Campaigns
Clean Between
Clean Between
Clean Between campaign was designed to highlight the importance of cleaning shared equipment between each use.
Clinell Ready
Clinell Ready
Initiative highlighting how working together helps reduce the spread of infection. Together we're ready for winter.
IIPW 2023 Moments that Matter
IIPW 2023 Moments that Matter
Join healthcare professionals around the world and celebrate the 'Moments that Matter'.
Webinars
Global Webinar Series
Global Webinar Series
Global Webinar Series provides support on IPC best practice for our partners and end users around the world.
UK Webinars
UK Webinars
Free webinars from GAMA Healthcare covering all aspects of IPC best practice for our customers based in the UK.
Latest news
Find out about the latest developments in the GAMA world, summaries of the recent research papers and read about our team, our events and the latest product launches.
Contact us
Contact us
Contact us
Find out how to contact us and see where our offices are across the globe. Or for general queries about orders or products, fill out the form and we'll be in touch soon.
Contact us
Find out how to contact us and see where our offices are across the globe. Or for general queries about orders or products, fill out the form and we'll be in touch soon.

About us
Products
Training
Research
Latest news
Contact us
How to buy

Back
Training
Training

Back
Research
Research

Back
Latest news
GAMA Blog
Campaigns
Webinars

Back
Contact us
Contact us

How to buy

Latest

A "halo" effect of chlorhexidine patient bathing: reduced environmental contamination

Posted

13th July 2018

Research

An Irish study has examined whether daily bathing of patients using chlorhexidine results in a "halo" effect, in reducing environmental contamination. The study found that contamination of surfaces with VRE and ESBL Enterobacteriaceae (ESBL-E) in the near-patient environment was significantly lower when chlorhexidine bathing was in operation.

The study was performed in a 12-bed mixed speciality ICU over 20 months including 157 patients, during which daily chlorhexidine bathing was introduced. Each occupied bed was sampled twice weekly for a range of antibiotic-resistant bacteria. 9.4% of 745 surfaces sampled prior to the introduction of chlorhexidine were contaminated with VRE or ESBL-E vs. 5.0% of 958 surfaces samples after (p<0.001). There was a stark and significant reduction in contamination with VRE or ESBL-E from hand-wash basins: before the introduction of chlorhexidine, 10% of hand-wash basins were contaminated (!), which fell to <2% after chlorhexidine was introduced.

The study evaluated a number of potentially confounding variables: hand hygiene compliance remained more or less the same, and bed occupancy and antibiotic usage increased. It is impressive that a reduction in contamination was observed despite increases in bed occupancy and antibiotic consumption, which have been shown to increase the risk of HCAI. The team even evaluated whether the ambient mean temperature differed between the two periods (it did not).

Although the study was performed in a single centre and no randomisation was involved, it was extraordinarily well controlled for the impact of potentially confounding variables. This study illustrates the "halo" effect of chlorhexidine daily bathing in reducing environmental contamination. This reduction in environmental contamination is likely to be a contributing factor to the improvement in clinical outcomes associated with chlorhexidine daily bathing.